InvestorsHub Logo
Followers 10
Posts 673
Boards Moderated 0
Alias Born 01/19/2014

Re: salgovernale69 post# 18761

Monday, 07/28/2014 11:32:34 PM

Monday, July 28, 2014 11:32:34 PM

Post# of 48316
I agree with you. My issue is public relations is a tactical game that is essential to an OTC biotech being successful and up listing. Assuming an NDA is not in place, ONCS is losing that fight. They are giving ammo to shorts and letting retail walk away. They will need to raise money again before they have revenue, and it will cost a much larger piece of the company if they can't keep retail holding shares tight. I think it is time to look to a PR firm that can manage website updates, schedules of events to the public, and bring in new shareholders. I want ONCS to be too busy to do these things. It is part of their growth. They just need to realize where they have weakness and lock it up.